comparison between Intralesional injection of 2% zinc sulfate and intralesional glucantime in treatment of cutaneous leishmaniasis.
Phase 1
Recruiting
- Conditions
- leishmaniasisSkin - Dermatological conditions
- Registration Number
- ACTRN12609000115235
- Lead Sponsor
- Kerman medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
the patients with urban cutaneous leishmaniasis with the onset of lower than 3 months
Exclusion Criteria
taking any treatment of leishmaniasis within last month
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method size of induration is measured with a transparent paper by an independed observer who was blind to the treat options['size of induration' is measured 'every 2 weeks until 10 weeks ( end of treatment); 2weeks after end of treatment and 3 months after end of treatment]
- Secondary Outcome Measures
Name Time Method smear for leishmaniasis[smear is taken at the end of treatment; 2weeks and 3 months after the end of treatment]